Natixis Advisors, L.P. Zoetis Inc. Transaction History
Natixis Advisors, L.P.
- $68.5 Billion
- Q3 2025
A detailed history of Natixis Advisors, L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 447,340 shares of ZTS stock, worth $53.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
447,340
Previous 878,982
49.11%
Holding current value
$53.1 Million
Previous $137 Million
52.25%
% of portfolio
0.1%
Previous 0.22%
Shares
33 transactions
Others Institutions Holding ZTS
# of Institutions
2,074Shares Held
423MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...